The aims are: 1. To identify, characterize and clone the pituitary receptor for growth hormone releasing factor (GRF). 2. To map the distribution of GRF receptors and mRNA throughout the body and test factors that may regulate GRF receptor message. 3. To perform structure/function studies that will reveal how receptor structure determines hormone selectivity and signal transduction. GRF is a peptide hormone released by the hypothalamus which acts on receptors in the anterior pituitary to stimulate the release of growth hormone. GRF is a member of the glucagon/secretin/VIP peptide family and is the major positive modulator controlling growth hormone release. Because of GRF's homology to VIP and secretin (whose receptors have recently been cloned) and because of the GRF receptor's sensitivity to GTP, the GRF receptor (GRF-R) is thought to be a member of the large family of G-protein coupled receptors with seven transmembrane spanning segments. The proposed experimental plan is to isolate and purify the receptor as a stable receptor-ligand complex, and to obtain amino acid sequences from receptor peptides. We have purified test amounts of the GRF receptor and have obtained a partial length cDNA clone by screening a human somatotroph tumor cDNA library for secretin receptor-like sequences. This sequence is similar to the VIP and secretin receptors and may be the GRF-R. Data suggests that we have found the full length of this cDNA clone. This clone will be sequenced and if it encodes a complete receptor we will test for GRF binding after transient expression in COS cells. The isolation and cloning of the GRF receptor and its in vitro expression will be of major importance in: 1. Understanding the receptors mechanism of action and its regulation. 2. Mapping the distribution of GRF receptors throughout the body and examining their physiological role outside the pituitary (if any). 3. Understanding its evolutionary relation to other G protein-linked receptors, especially others in the glucagon/secretin/VIP family. 4. Screening large numbers of analogs and xenobiotics for GRF activity. This could lead to improved agonists for use in clinical therapy to augment growth hormone secretion. This screening, together with modeling based on receptor structure, could lead to orally active nonpeptide GRF agonists that would be useful in medical practice and also in the development of higher yield milk production and higher yield, leaner livestock.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK045350-01A1
Application #
3246865
Study Section
Biochemical Endocrinology Study Section (BCE)
Project Start
1993-05-01
Project End
1997-04-30
Budget Start
1993-05-01
Budget End
1994-04-30
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Virginia
Department
Type
Schools of Medicine
DUNS #
001910777
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Harvey, S; Gineste, C; Gaylinn, B D (2014) Growth hormone (GH)-releasing activity of chicken GH-releasing hormone (GHRH) in chickens. Gen Comp Endocrinol 204:261-6
Toogood, Andrew A; Harvey, Stephen; Thorner, Michael O et al. (2006) Cloning of the chicken pituitary receptor for growth hormone-releasing hormone. Endocrinology 147:1838-46
Horikawa, R; Gaylinn, B D; Lyons Jr, C E et al. (2001) Molecular cloning of ovine and bovine growth hormone-releasing hormone receptors: the ovine receptor is C-terminally truncated. Endocrinology 142:2660-8
Pombo, C M; Zalvide, J; Gaylinn, B D et al. (2000) Growth hormone-releasing hormone stimulates mitogen-activated protein kinase. Endocrinology 141:2113-9
Nass, R; Gilrain, J; Anderson, S et al. (2000) High plasma growth hormone (GH) levels inhibit expression of GH secretagogue receptor messenger ribonucleic acid levels in the rat pituitary. Endocrinology 141:2084-9
Thorner, M O (1999) The discovery of growth hormone-releasing hormone. J Clin Endocrinol Metab 84:4671-6
Gaylinn, B D; Dealmeida, V I; Lyons Jr, C E et al. (1999) The mutant growth hormone-releasing hormone (GHRH) receptor of the little mouse does not bind GHRH. Endocrinology 140:5066-74
Lopes, M B; Gaylinn, B D; Thorner, M O et al. (1997) Growth hormone-releasing hormone receptor mRNA in acromegalic pituitary tumors. Am J Pathol 150:1885-91
Zysk, J R; Gaylinn, B D; Lyons, C E et al. (1996) Purification of the growth hormone releasing hormone receptor with a C-terminal, biotinylated affinity ligand. Biochem Biophys Res Commun 221:133-9
Horikawa, R; Hellmann, P; Cella, S G et al. (1996) Growth hormone-releasing factor (GRF) regulates expression of its own receptor. Endocrinology 137:2642-5

Showing the most recent 10 out of 12 publications